ECS BOTANICS HOLDINGS LTD — Capital/Financing Update 2021

Mar 22, 2021

ASX Announcement 23 March 2021

==> picture [168 x 78] intentionally omitted <==

Correction to Typographical Error in Entitlement Offer Prospectus

It has come to the attention of ECS Botanics Holdings Ltd (ASX: ECS or Company ) that there is a typographical error in the Entitlement Offer Prospectus (“Entitlement Offer Prospectus”).

The error is in section 1.6, which relates to rounding. The Entitlement Offer Prospectus incorrectly states that “ any fractional Entitlement will be rounded up to the nearest whole number ”.

The correct statement should read “ any fractional Entitlement of 0.5 or more will be rounded up to the nearest whole number ”.

Your Faithfully

==> picture [86 x 30] intentionally omitted <==

Mauro Piccini Company Secretary

About ECS Botanics

ECS Botanics is a vertically integrated medicinal cannabis and industrial hemp business. The company owns farms and medicinal cannabis facilities in Tasmania and Victoria for the cultivation, processing, and manufacturing of medicinal cannabis. ECS manufacturers to EU GMP standards and also has the necessary licenses to cultivate and manufacture medicinal cannabis for the wholesale extract, final dose and premium dry flower market. ECS cultivates hemp for the wholesale market and its retail food and wellness brand, while having obtained all the necessary licenses to grow, supply and manufacture. ECS’s core focus is scale and low cost production, without compromising quality.

For further information, please contact:

Alexander Keach Jason Hine Managing Director Chief Operations Officer alex@ecsbotanics.com.au jason@ecsbotanics.com.au +61 419 323 059 +61 419 922 259

Authorised on behalf of ECS by Alex Keach, Managing Director

ECS Botanics Holdings Ltd ACN 009 805 298 GPO Box 5216 George Street Mail Centre 2001 Cressy Tasmania 7302 reception@ecsbotanics.com.au - www.ecsbotanics.com.au